Paclitaxel liposomal - Sun Pharma Advanced Research Company

Drug Profile

Paclitaxel liposomal - Sun Pharma Advanced Research Company

Alternative Names: Liposome-encapsulated paclitaxel - Sun Pharma Advanced Research Company; Paclitaxel injection concentrate for nanodispersion; Paclitaxel nanodispersion - Sun Pharma Advanced Research Company; PICN; SPARC1023; SPARC1028; SPARC1612

Latest Information Update: 04 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Sun Pharma Advanced Research Company
  • Class Antineoplastics; Diterpenes; Paclitaxels; Small molecules; Taxanes
  • Mechanism of Action Tubulin inhibitors; Tubulin polymerisation inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Breast cancer
  • Phase II Solid tumours

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for phase-I development in Solid-tumours in India (IV, Injection)
  • 01 Oct 2016 Sun Pharma completes a phase-I trial in Solid tumours (Combination therapy, Monotherapy, Late-stage disease) in USA (NCT01304303)
  • 22 Jun 2016 Sun Pharma plans a phase I trial for Breast cancer (Late-stage disease, Metastatic disease) in India (CTRI/2016/06/007043)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top